Alloisoleucine differentiates the branched-chain aminoacidemia of Zucker and dietary obese rats

Obesity

Volumn 22, Issue 5, 2014, Pages 1212-1215

  Olson, Kristine C ^a   Chen, Gang ^a   Xu, Yuping ^a   Hajnal, Andras ^a   Lynch, Christopher J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

alloisoleucine; branched chain amino acid transaminase; branched chain amino acids; isoleucine; maple syrup urine disease

Indexed keywords

2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); ALLOISOLEUCINE; BRANCHED CHAIN AMINO ACID; PHENYLALANINE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; ISOLEUCINE;

AMINO ACID BLOOD LEVEL; AMINOACIDEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; ENZYME ACTIVITY; MALE; MAPLE SYRUP URINE DISEASE; MASS SPECTROMETRY; NONHUMAN; OBESITY; PREDICTIVE VALUE; PROTEIN FUNCTION; RAT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ZUCKER DIABETIC FATTY RAT; ZUCKER RAT; ADIPOSE TISSUE; ANIMAL; BLOOD; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; LIPID DIET; LIQUID CHROMATOGRAPHY; METABOLISM;

ACER; RATTUS;

3-METHYL-2-OXOBUTANOATE DEHYDROGENASE (LIPOAMIDE); ADIPOSE TISSUE; AMINO ACID METABOLISM, INBORN ERRORS; ANIMALS; CHROMATOGRAPHY, LIQUID; DIET, HIGH-FAT; ISOLEUCINE; MALE; OBESITY; RATS; RATS, ZUCKER;

EID: 84899990871     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20691     Document Type: Article

References (20)

1. Layman DK, Walker DA,. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr 2006; 136: 319S-23S.
2. Blouet C, Jo YH, Li X, Schwartz GJ,. Mediobasal hypothalamic leucine sensing regulates food intake through activation of a hypothalamus-brainstem circuit. J Neurosci 2009; 29: 8302-8311.
3. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9: 311-326.
4. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011; 17: 448-453.
5. Adams SH,. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr 2011; 2: 445-456.
6. Kadota Y, Toyoda T, Kitaura Y, Adams SH, Shimomura Y,. Regulation of hepatic branched-chain α-ketoacid dehydrogenase complex in rats fed a high-fat diet. Obesity Res Clin Pract 2013; 7: e439-e444.
7. Lackey DE, Lynch CJ, Olson KC, et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab 2013; 304: E1175-E1187.
8. She P, Olson KC, Kadota Y, et al. Leucine and protein metabolism in obese Zucker rats. PLoS One 2013; 8: e59443.
9. She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ,. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab 2007; 293: E1552-E1563.
10. Zimmerman HA, Olson KC, Chen G, Lynch CJ,. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice. Mol Genet Metab 2013; 109: 345-353.
11. Kuzuya T, Katano Y, Nakano I, et al. Regulation of branched-chain amino acid catabolism in rat models for spontaneous type 2 diabetes mellitus. Biochem Biophys Res Commun 2008; 373: 94-98.
12. Oyarzabal A, Martinez-Pardo M, Merinero B, et al. A novel regulatory defect in the branched-chain alpha-keto acid dehydrogenase complex due to a mutation in the PPM1K gene causes a mild variant phenotype of maple syrup urine disease. Hum Mutat 2013; 34: 355-362.
13. Bridi R, Braun CA, Zorzi GK, et al. Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis 2005; 20: 155-167.
14. Taneera J, Lang S, Sharma A, et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab 2012; 16: 122-134.
15. Tiffin N, Adie E, Turner F, et al. Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes. Nucleic Acids Res 2006; 34: 3067-3081.
16. Xu M, Qi Q, Liang J, et al. Genetic determinant for amino acid metabolites and changes in body weight and insulin resistance in response to weight-loss diets: the preventing overweight using novel dietary strategies (POUNDS LOST) trial. Circulation 2013; 127: 1283-1289.
17. Sun H, Lu G, Ren S, Chen J, Wang Y,. Catabolism of branched-chain amino acids in heart failure: insights from genetic models. Pediatr Cardiol 2011; 32: 305-310.
18. Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U,. Significance of l -alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem 1999; 45: 1734-1740.
19. Oglesbee D, Sanders KA, Lacey JM, et al. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD). Clin Chem 2008; 54: 542-549.
20. Mamer OA, Reimer ML,. On the mechanisms of the formation of L-alloisoleucine and the 2-hydroxy-3-methylvaleric acid stereoisomers from l -isoleucine in maple syrup urine disease patients and in normal humans. J Biol Chem 1992; 267: 22141-22147.